Logo image of SGHT

SIGHT SCIENCES INC (SGHT) Stock Fundamental Analysis

NASDAQ:SGHT - Nasdaq - US82657M1053 - Common Stock - Currency: USD

2.8  +0.07 (+2.56%)

After market: 2.8 0 (0%)

Fundamental Rating

3

Taking everything into account, SGHT scores 3 out of 10 in our fundamental rating. SGHT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While SGHT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, SGHT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SGHT has reported negative net income.
SGHT had a negative operating cash flow in the past year.
SGHT had negative earnings in each of the past 5 years.
In the past 5 years SGHT always reported negative operating cash flow.
SGHT Yearly Net Income VS EBIT VS OCF VS FCFSGHT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

SGHT has a Return On Assets of -35.06%. This is comparable to the rest of the industry: SGHT outperforms 42.63% of its industry peers.
SGHT has a Return On Equity (-53.03%) which is in line with its industry peers.
Industry RankSector Rank
ROA -35.06%
ROE -53.03%
ROIC N/A
ROA(3y)-32.09%
ROA(5y)-45.64%
ROE(3y)-42.4%
ROE(5y)-103.68%
ROIC(3y)N/A
ROIC(5y)N/A
SGHT Yearly ROA, ROE, ROICSGHT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

The Gross Margin of SGHT (85.11%) is better than 96.84% of its industry peers.
In the last couple of years the Gross Margin of SGHT has grown nicely.
SGHT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.57%
GM growth 5Y4.37%
SGHT Yearly Profit, Operating, Gross MarginsSGHT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

SGHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SGHT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SGHT has been increased compared to 5 years ago.
Compared to 1 year ago, SGHT has a worse debt to assets ratio.
SGHT Yearly Shares OutstandingSGHT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
SGHT Yearly Total Debt VS Total AssetsSGHT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

SGHT has an Altman-Z score of -1.08. This is a bad value and indicates that SGHT is not financially healthy and even has some risk of bankruptcy.
SGHT's Altman-Z score of -1.08 is on the low side compared to the rest of the industry. SGHT is outperformed by 60.53% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that SGHT is not too dependend on debt financing.
SGHT has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z -1.08
ROIC/WACCN/A
WACC9.57%
SGHT Yearly LT Debt VS Equity VS FCFSGHT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 10.18 indicates that SGHT has no problem at all paying its short term obligations.
SGHT's Current ratio of 10.18 is amongst the best of the industry. SGHT outperforms 92.63% of its industry peers.
A Quick Ratio of 9.74 indicates that SGHT has no problem at all paying its short term obligations.
The Quick ratio of SGHT (9.74) is better than 93.16% of its industry peers.
Industry RankSector Rank
Current Ratio 10.18
Quick Ratio 9.74
SGHT Yearly Current Assets VS Current LiabilitesSGHT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

SGHT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.69%, which is quite good.
SGHT shows a decrease in Revenue. In the last year, the revenue decreased by -3.98%.
Measured over the past years, SGHT shows a very strong growth in Revenue. The Revenue has been growing by 60.84% on average per year.
EPS 1Y (TTM)19.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y43.14%
Revenue growth 5Y60.84%
Sales Q2Q%0.74%

3.2 Future

SGHT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.96% yearly.
Based on estimates for the next years, SGHT will show a quite strong growth in Revenue. The Revenue will grow by 8.51% on average per year.
EPS Next Y13.13%
EPS Next 2Y12.03%
EPS Next 3Y13.97%
EPS Next 5Y13.96%
Revenue Next Year-0.37%
Revenue Next 2Y2.18%
Revenue Next 3Y6.57%
Revenue Next 5Y8.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SGHT Yearly Revenue VS EstimatesSGHT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
SGHT Yearly EPS VS EstimatesSGHT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SGHT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SGHT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGHT Price Earnings VS Forward Price EarningsSGHT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGHT Per share dataSGHT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as SGHT's earnings are expected to grow with 13.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.03%
EPS Next 3Y13.97%

More info and screens

0

5. Dividend

5.1 Amount

SGHT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGHT SCIENCES INC

NASDAQ:SGHT (2/4/2025, 8:07:23 PM)

After market: 2.8 0 (0%)

2.8

+0.07 (+2.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners50.96%
Inst Owner Change25.74%
Ins Owners19.42%
Ins Owner Change0.45%
Market Cap142.10M
Analysts74.29
Price Target4.61 (64.64%)
Short Float %2.66%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.64%
Min EPS beat(2)-3.91%
Max EPS beat(2)17.2%
EPS beat(4)2
Avg EPS beat(4)6.97%
Min EPS beat(4)-17.36%
Max EPS beat(4)31.96%
EPS beat(8)6
Avg EPS beat(8)11.08%
EPS beat(12)8
Avg EPS beat(12)5.77%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)-1.86%
Revenue beat(4)1
Avg Revenue beat(4)-1.3%
Min Revenue beat(4)-3.12%
Max Revenue beat(4)2.75%
Revenue beat(8)2
Avg Revenue beat(8)-1.84%
Revenue beat(12)6
Avg Revenue beat(12)0.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.78%
PT rev (3m)-38.8%
EPS NQ rev (1m)5.46%
EPS NQ rev (3m)-7.11%
EPS NY rev (1m)4.37%
EPS NY rev (3m)-0.28%
Revenue NQ rev (1m)-1.83%
Revenue NQ rev (3m)-9.65%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-1.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS1.57
BVpS1.87
TBVpS1.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.06%
ROE -53.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.11%
FCFM N/A
ROA(3y)-32.09%
ROA(5y)-45.64%
ROE(3y)-42.4%
ROE(5y)-103.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.57%
GM growth 5Y4.37%
F-Score3
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.77%
Cap/Sales 0.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.18
Quick Ratio 9.74
Altman-Z -1.08
F-Score3
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)131.34%
Cap/Depr(5y)158.02%
Cap/Sales(3y)1.33%
Cap/Sales(5y)2.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.52%
EPS Next Y13.13%
EPS Next 2Y12.03%
EPS Next 3Y13.97%
EPS Next 5Y13.96%
Revenue 1Y (TTM)-3.98%
Revenue growth 3Y43.14%
Revenue growth 5Y60.84%
Sales Q2Q%0.74%
Revenue Next Year-0.37%
Revenue Next 2Y2.18%
Revenue Next 3Y6.57%
Revenue Next 5Y8.51%
EBIT growth 1Y21.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.87%
EBIT Next 3Y17.63%
EBIT Next 5YN/A
FCF growth 1Y64.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.35%
OCF growth 3YN/A
OCF growth 5YN/A